These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25434600)

  • 21. Activation of Shigella flexneri type 3 secretion requires a host-induced conformational change to the translocon pore.
    Russo BC; Duncan JK; Wiscovitch AL; Hachey AC; Goldberg MB
    PLoS Pathog; 2019 Nov; 15(11):e1007928. PubMed ID: 31725799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling.
    Pore D; Mahata N; Pal A; Chakrabarti MK
    Mol Immunol; 2010 May; 47(9):1739-46. PubMed ID: 20347487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human pathogenic bacterium Shigella proliferates in plants through adoption of type III effectors for shigellosis.
    Jo SH; Lee J; Park E; Kim DW; Lee DH; Ryu CM; Choi D; Park JM
    Plant Cell Environ; 2019 Nov; 42(11):2962-2978. PubMed ID: 31250458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen.
    Lucchini S; Liu H; Jin Q; Hinton JC; Yu J
    Infect Immun; 2005 Jan; 73(1):88-102. PubMed ID: 15618144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus.
    Chamekh M; Phalipon A; Quertainmont R; Salmon I; Sansonetti P; Allaoui A
    J Immunol; 2008 Mar; 180(6):4292-8. PubMed ID: 18322242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses.
    Okuda J; Toyotome T; Kataoka N; Ohno M; Abe H; Shimura Y; Seyedarabi A; Pickersgill R; Sasakawa C
    Biochem Biophys Res Commun; 2005 Jul; 333(2):531-9. PubMed ID: 15950937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread.
    Santapaola D; Del Chierico F; Petrucca A; Uzzau S; Casalino M; Colonna B; Sessa R; Berlutti F; Nicoletti M
    J Bacteriol; 2006 Feb; 188(4):1620-7. PubMed ID: 16452446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shigella effector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation.
    Otsubo R; Mimuro H; Ashida H; Hamazaki J; Murata S; Sasakawa C
    Cell Microbiol; 2019 Mar; 21(3):e12974. PubMed ID: 30414351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate filaments enable pathogen docking to trigger type 3 effector translocation.
    Russo BC; Stamm LM; Raaben M; Kim CM; Kahoud E; Robinson LR; Bose S; Queiroz AL; Herrera BB; Baxt LA; Mor-Vaknin N; Fu Y; Molina G; Markovitz DM; Whelan SP; Goldberg MB
    Nat Microbiol; 2016 Mar; 1():16025. PubMed ID: 27572444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shigella infection interferes with SUMOylation and increases PML-NB number.
    Sidik SM; Salsman J; Dellaire G; Rohde JR
    PLoS One; 2015; 10(4):e0122585. PubMed ID: 25848798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The phosphothreonine lyase activity of a bacterial type III effector family.
    Li H; Xu H; Zhou Y; Zhang J; Long C; Li S; Chen S; Zhou JM; Shao F
    Science; 2007 Feb; 315(5814):1000-3. PubMed ID: 17303758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection.
    Kasper CA; Sorg I; Schmutz C; Tschon T; Wischnewski H; Kim ML; Arrieumerlou C
    Immunity; 2010 Nov; 33(5):804-16. PubMed ID: 21093316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interfacial amino acids support Spa47 oligomerization and shigella type three secretion system activation.
    Demler HJ; Case HB; Morales Y; Bernard AR; Johnson SJ; Dickenson NE
    Proteins; 2019 Nov; 87(11):931-942. PubMed ID: 31162724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells.
    Klimpel GR; Niesel DW; Klimpel KD
    J Immunol; 1986 Feb; 136(3):1081-6. PubMed ID: 3510252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil antimicrobial proteins enhance Shigella flexneri adhesion and invasion.
    Eilers B; Mayer-Scholl A; Walker T; Tang C; Weinrauch Y; Zychlinsky A
    Cell Microbiol; 2010 Aug; 12(8):1134-43. PubMed ID: 20331641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
    Pore D; Chakrabarti MK
    Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.
    Schmutz C; Ahrné E; Kasper CA; Tschon T; Sorg I; Dreier RF; Schmidt A; Arrieumerlou C
    Mol Cell Proteomics; 2013 Oct; 12(10):2952-68. PubMed ID: 23828894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Shigella flexneri-mediated infections in model organism Caenorhabditis elegans.
    Kesika P; Karutha Pandian S; Balamurugan K
    Scand J Infect Dis; 2011 Apr; 43(4):286-95. PubMed ID: 21254954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The class II phosphatidylinositol 3-phosphate kinase PIK3C2A promotes Shigella flexneri dissemination through formation of vacuole-like protrusions.
    Dragoi AM; Agaisse H
    Infect Immun; 2015 Apr; 83(4):1695-704. PubMed ID: 25667265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.